Correction of Fragile X Syndrome in Mice
暂无分享,去创建一个
Mark F. Bear | Sumantra Chattarji | M. Bear | S. Chattarji | Benjamin D. Auerbach | Gül Dölen | Gül Dölen | Emily K. Osterweil | Emily Osterweil | B. S. Shankaranarayana Rao | Gordon B. Smith | E. Osterweil | B. Rao
[1] Gerald M Edelman,et al. Dendritic spines elongate after stimulation of group 1 metabotropic glutamate receptors in cultured hippocampal neurons , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[2] Mark F. Bear,et al. Altered synaptic plasticity in a mouse model of fragile X mental retardation , 2002, Proceedings of the National Academy of Sciences of the United States of America.
[3] M. Stryker,et al. Rapid Ocular Dominance Plasticity Requires Cortical but Not Geniculate Protein Synthesis , 2002, Neuron.
[4] Yan Wang,et al. Pharmacological Rescue of Synaptic Plasticity, Courtship Behavior, and Mushroom Body Defects in a Drosophila Model of Fragile X Syndrome , 2005, Neuron.
[5] I. Weiler,et al. Metabotropic glutamate receptors trigger postsynaptic protein synthesis. , 1993, Proceedings of the National Academy of Sciences of the United States of America.
[6] M. Bear,et al. Role for rapid dendritic protein synthesis in hippocampal mGluR-dependent long-term depression. , 2000, Science.
[7] P. Bergold,et al. Requirement of protein synthesis for group I mGluR-mediated induction of epileptiform discharges. , 1998, Journal of neurophysiology.
[8] M. Tranfaglia,et al. Suppression of two major Fragile X Syndrome mouse model phenotypes by the mGluR5 antagonist MPEP , 2005, Neuropharmacology.
[9] K. Hsu,et al. The Group I Metabotropic Glutamate Receptor Agonist (S)-3,5-Dihydroxyphenylglycine Induces a Novel Form of Depotentiation in the CA1 Region of the Hippocampus , 2002, The Journal of Neuroscience.
[10] Guy Nagels,et al. Fmr1 knockout mice: A model to study fragile X mental retardation , 1994, Cell.
[11] J. Darnell,et al. Microarray Identification of FMRP-Associated Brain mRNAs and Altered mRNA Translational Profiles in Fragile X Syndrome , 2001, Cell.
[12] A. Faden,et al. Metabotropic glutamate receptor subtype 5 antagonists MPEP and MTEP. , 2006, CNS drug reviews.
[13] H. Schiöth,et al. The Phylogenetic Relationship of the Glutamate and Pheromone G‐Protein‐Coupled Receptors in Different Vertebrate Species , 2005, Annals of the New York Academy of Sciences.
[14] Wim E Crusio,et al. Fmr1 KO Mice as a Possible Model of Autistic Features , 2006, TheScientificWorldJournal.
[15] A. Newman,et al. Design and synthesis of novel heterobiaryl amides as metabotropic glutamate receptor subtype 5 antagonists. , 2007, Bioorganic & medicinal chemistry letters.
[16] Michael Lardelli,et al. Contribution of mGluR and Fmr1 functional pathways to neurite morphogenesis, craniofacial development and fragile X syndrome. , 2006, Human molecular genetics.
[17] I. Weiler,et al. Local Protein Synthesis and Spine Morphogenesis: Fragile X Syndrome and Beyond , 2006, The Journal of Neuroscience.
[18] Richard Paylor,et al. Dynamic Translational and Proteasomal Regulation of Fragile X Mental Retardation Protein Controls mGluR-Dependent Long-Term Depression , 2006, Neuron.
[19] E. De Schutter,et al. Deletion of FMR1 in Purkinje Cells Enhances Parallel Fiber LTD, Enlarges Spines, and Attenuates Cerebellar Eyelid Conditioning in Fragile X Syndrome , 2005, Neuron.
[20] M. Bear,et al. Chemical induction of mGluR5- and protein synthesis--dependent long-term depression in hippocampal area CA1. , 2001, Journal of neurophysiology.
[21] D. Nelson,et al. (Over)correction of FMR1 deficiency with YAC transgenics: behavioral and physical features. , 2000, Human molecular genetics.
[22] J. Roder,et al. Selective abolition of the NMDA component of long-term potentiation in mice lacking mGluR5. , 1998, Learning & memory.
[23] C. B. Smith,et al. Postadolescent Changes in Regional Cerebral Protein Synthesis: An In Vivo Study in the Fmr1 Null Mouse , 2005, The Journal of Neuroscience.
[24] R. Wong,et al. Prolonged Epileptiform Discharges Induced by Altered Group I Metabotropic Glutamate Receptor-Mediated Synaptic Responses in Hippocampal Slices of a Fragile X Mouse Model , 2005, The Journal of Neuroscience.
[25] Jonathan R. Whitlock,et al. Learning Induces Long-Term Potentiation in the Hippocampus , 2006, Science.
[26] J. D. McGaugh,et al. Anisomycin infused into the hippocampus fails to block "reconsolidation" but impairs extinction: the role of re-exposure duration. , 2006, Learning & memory.
[27] D. Loesch,et al. Growth in stature in fragile X families: a mixed longitudinal study. , 1995, American journal of medical genetics.
[28] J. Roder,et al. Mice Lacking Metabotropic Glutamate Receptor 5 Show Impaired Learning and Reduced CA1 Long-Term Potentiation (LTP) But Normal CA3 LTP , 1997, The Journal of Neuroscience.
[29] M. Bear,et al. Fragile X: Translation in Action , 2008, Neuropsychopharmacology.
[30] Susumu Tonegawa,et al. Altered Cortical Synaptic Morphology and Impaired Memory Consolidation in Forebrain- Specific Dominant-Negative PAK Transgenic Mice , 2004, Neuron.
[31] W. Abraham,et al. Metabotropic Glutamate Receptors Trigger Homosynaptic Protein Synthesis to Prolong Long-Term Potentiation , 2000, The Journal of Neuroscience.
[32] H. Robertson. Audiogenic seizures: increased benzodiazepin receptor binding in a susceptible strain of mice. , 1980, European journal of pharmacology.
[33] M. Ito,et al. Induction of long-term depression in cerebellar Purkinje cells requires a rapidly turned over protein. , 2001, Journal of neurophysiology.
[34] Mark F. Bear,et al. How Monocular Deprivation Shifts Ocular Dominance in Visual Cortex of Young Mice , 2004, Neuron.
[35] M. Bear,et al. A biochemical correlate of the critical period for synaptic modification in the visual cortex. , 1989, Science.
[36] Mark F Bear,et al. The mGluR theory of fragile X mental retardation , 2004, Trends in Neurosciences.
[37] D. Condorelli,et al. Expression of metabotropic glutamate receptors in the rat and human testis. , 2001, The Journal of endocrinology.
[38] C. Heidbreder,et al. Evidence that the metabotropic glutamate receptor 5 antagonist MPEP may act as an inhibitor of the norepinephrine transporter in vitro and in vivo , 2003, Synapse.